TY - JOUR
T1 - Cervical perimedullary arteriovenous shunts
T2 - A study of 22 consecutive cases with a focus on angioarchitecture and surgical approaches
AU - Endo, Toshiki
AU - Shimizu, Hiroaki
AU - Sato, Kenichi
AU - Niizuma, Kuniyasu
AU - Kondo, Ryushi
AU - Matsumoto, Yasushi
AU - Takahashi, Akira
AU - Tominaga, Teiji
PY - 2014/9
Y1 - 2014/9
N2 - BACKGROUND:: Reports of cervical perimedullary arteriovenous shunt (PMAVS) are limited, and treatment strategies have not been established. OBJECTIVE:: To describe angioarchitecture and optimal treatment strategies for cervical PMAVS. METHODS:: We treated 22 patients with cervical PMAVS between 2000 and 2012 (8 women and 14 men; age, 9-80 years). According to the classification, our patients included type IVa (4 patients), type IVb (16 patients), and type IVc (2 patients). Seventeen patients presented with subarachnoid hemorrhage. RESULTS:: A total of 41 shunting points were localized in 22 patients, of which 34 points were located ventral or ventrolateral to the spinal cord. The anterior spinal artery (ASA) contributed to the shunts in 16 patients. Aneurysm formation was identified in 8 patients. Endovascular treatment was attempted in 3 patients, resulting in complete obliteration in 1 patient (type IVc). Overall, 21 patients underwent open surgery. An anterior approach with corpectomy was elected for 2 patients; the other 19 patients underwent the posterior approaches using indocyanine green videoangiography, intraoperative angiography, endoscopy (8 patients), and neuromonitoring. Twenty patients were rated as having a good recovery at 6 months after surgery. No recurrence was observed in any patients during the follow-up (mean, 59.7 months). CONCLUSION:: Shunting points of the cervical PMAVS were predominantly located ventral or ventrolateral to the spinal cord and were often fed by the ASA. Even for ventral lesions, posterior exposure assisted with neuromonitoring and endoscopy, and intraoperative angiography provided a view sufficient to understand the relationships between the shunts and the ASA and contributed to good surgical outcomes.
AB - BACKGROUND:: Reports of cervical perimedullary arteriovenous shunt (PMAVS) are limited, and treatment strategies have not been established. OBJECTIVE:: To describe angioarchitecture and optimal treatment strategies for cervical PMAVS. METHODS:: We treated 22 patients with cervical PMAVS between 2000 and 2012 (8 women and 14 men; age, 9-80 years). According to the classification, our patients included type IVa (4 patients), type IVb (16 patients), and type IVc (2 patients). Seventeen patients presented with subarachnoid hemorrhage. RESULTS:: A total of 41 shunting points were localized in 22 patients, of which 34 points were located ventral or ventrolateral to the spinal cord. The anterior spinal artery (ASA) contributed to the shunts in 16 patients. Aneurysm formation was identified in 8 patients. Endovascular treatment was attempted in 3 patients, resulting in complete obliteration in 1 patient (type IVc). Overall, 21 patients underwent open surgery. An anterior approach with corpectomy was elected for 2 patients; the other 19 patients underwent the posterior approaches using indocyanine green videoangiography, intraoperative angiography, endoscopy (8 patients), and neuromonitoring. Twenty patients were rated as having a good recovery at 6 months after surgery. No recurrence was observed in any patients during the follow-up (mean, 59.7 months). CONCLUSION:: Shunting points of the cervical PMAVS were predominantly located ventral or ventrolateral to the spinal cord and were often fed by the ASA. Even for ventral lesions, posterior exposure assisted with neuromonitoring and endoscopy, and intraoperative angiography provided a view sufficient to understand the relationships between the shunts and the ASA and contributed to good surgical outcomes.
KW - 3-Dimensional fusion image
KW - Anterior spinal artery
KW - Endoscopy
KW - Indocyanine green videoangiography
KW - Perimedullary arteriovenous shunt
KW - Spinal arteriovenous malformation
UR - http://www.scopus.com/inward/record.url?scp=84908356507&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908356507&partnerID=8YFLogxK
U2 - 10.1227/NEU.0000000000000401
DO - 10.1227/NEU.0000000000000401
M3 - Article
C2 - 24867200
AN - SCOPUS:84908356507
SN - 0148-396X
VL - 75
SP - 238
EP - 249
JO - Neurosurgery
JF - Neurosurgery
IS - 3
ER -